Chronic Fatigue Syndrome Market is segmented By Treatment (Pharmacological Treatments, Non-Pharmacological Treatments), By Distribution Channel (Hospital Pharmacies, Reta ....
Market Size in USD
CAGR5.2%
Study Period | 2024 - 2031 |
Base Year of Estimation | 2023 |
CAGR | 5.2% |
Market Concentration | High |
Major Players | Hemispherx Biopharma, Inc., Cortene Inc., Mitsubishi Tanabe Pharma Corporation, NanoViricides, Inc., Tonix Pharmaceuticals Holding Corp. |
The chronic fatigue syndrome market is estimated to be valued at USD 13.15 Bn in 2024 and is expected to reach USD 18.75 Bn by 2031, growing at a compound annual growth rate (CAGR) of 5.2% from 2024 to 2031. Growing prevalence of chronic fatigue syndrome around the globe is the major factor driving the market's growth. Additionally, rising awareness regarding the availability of treatment is another important factor pushing the market upwards.